Taxus chinensis
Taxus chinensis
Taxus chinensis, also known as Chinese yew, is a traditional medicine plant native to East Asia. While it has been used in various Asian herbal traditions for centuries, specific traditional uses have not been extensively documented. Scientific evidence suggests potential therapeutic applications; for instance, studies indicate that exosomal-cisplatin nanoplatforms derived from Taxus chinensis could enhance treatment efficacy while reducing systemic toxicity for certain cancers, particularly triple-negative breast cancer (TNBC). Additionally, Taxus tablets demonstrated comparable antitumor efficacy to paclitaxel injections with good tolerability, supporting their potential as oral antitumor agents. Compounds 4 and 5 from the varietal Taxus chinensis var. mairei showed significant triglyceride-lowering activity in adipocytes, with IC50 values comparable to fenofibrate, indicating possible benefits for lipid metabolism. No major safety concerns or recorded drug interactions have been identified thus far.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- This study presented an exosomal-cisplatin nanoplatform derived from Taxus chinensis for TNBC treatment, showing enhanced therapeutic efficacy with reduced systemic toxicity.
- Taxus tablets showed comparable antitumor efficacy to PTX injection with good tolerance, supporting their development as an oral antitumor agent.
- Hongwu mixture (HWM) inhibited triple-negative breast cancer cell proliferation and promoted apoptosis by regulating ZNF143/SAV1 signaling.
- Compounds 4 and 5 from Taxus chinensis var. mairei showed significant triglyceride-lowering activity in adipocytes, with IC50 values comparable to fenofibrate.
Frequently asked questions
What is Taxus chinensis?
Taxus chinensis (Taxus chinensis) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Taxus chinensis?
4 sourced findings are recorded for Taxus chinensis; the strongest carries evidence grade D. For example: This study presented an exosomal-cisplatin nanoplatform derived from Taxus chinensis for TNBC treatment, showing enhanced therapeutic efficacy with reduced systemic toxicity.
How strong is the evidence for Taxus chinensis?
The strongest finding for Taxus chinensis carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Taxus chinensis safe? What are the side effects?
No major safety issues are recorded for Taxus chinensis in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Taxus chinensis interact with medications?
No drug interactions are recorded for Taxus chinensis in our sources. This does not rule them out — check with a pharmacist.
Is Taxus chinensis a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Hongwu mixture exerts inhibition on triple-negative breast cancer by regulating SAV1/Hippo signaling through ZNF143. literature abstract metadata
- T2 A semimechanistic PK/PD model-informed Taxus tablets' development: Accelerating early clinical translation of a taxane-based antitumor agent. literature abstract metadata
- T2 Intelligent plant exosomes synergize miRNAs and cisplatin for spatiotemporally precise multimodal treatment for TNBC with high safety. literature abstract metadata
- T2 2(3→20)-abeo-taxoids with adipogenesis inhibitory activity from the leaves and twigs of Taxus chinensis var. mairei. literature abstract metadata